Matthias Szabolcs

Columbia University Irving Medical Center — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

42h-index6.7kcitations128works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer-related molecular mechanisms research(21), Cancer Genomics and Diagnostics(14), Nitric Oxide and Endothelin Effects(13), Cardiac Ischemia and Reperfusion(11), Pancreatic and Hepatic Oncology Research(10)

Publications128 total

Dominant intragraft plasma cells targeting bilirubin implicate local heme catabolism in human cardiac allograft vasculopathy
Journal of Clinical Investigation·2025· 1 citedOpen Access
New standards in HER2-low testing: the CASI-01 comparative methods study
EBioMedicine·2025· 3 citedOpen Access
New Standards in Her2-Low Testing: The Casi-01 Comparative Methods Study
SSRN Electronic Journal·2025· 1 citedOpen Access
Biallelic potential disease-causing missense variants in TAF1A in two siblings with infantile restrictive cardiomyopathy
European Journal of Medical Genetics·2024Open Access
Histological characterisation of pulmonary monkeypox virus infection in a patient with <scp>AIDS</scp>
Histopathology·2024Open Access
In Support of Magnani and Taylor
Archives of Pathology & Laboratory Medicine·2023· 4 citedOpen Access
List of contributors
Diagnostic Molecular Pathology·2023
Molecular and serological testing in the setting of a global pandemic
Diagnostic Molecular Pathology·2023
A Right Atrial Mass Discovered Postpartum: A Diagnostic Challenge
CASE·2023· 2 citedOpen Access
Supplementary Figure 3 from HMGA2 Is a Driver of Tumor Metastasis
2023Open Access
Supplementary Tables 1 - 2 from Hypomethylating Therapy in an Aggressive Stroma-Rich Model of Pancreatic Carcinoma
2023Open Access
Supplementary Figure 8 from HMGA2 Is a Driver of Tumor Metastasis
2023Open Access
Supplementary Figure 7 from HMGA2 Is a Driver of Tumor Metastasis
2023Open Access
Supplementary Figure 9 from HMGA2 Is a Driver of Tumor Metastasis
2023Open Access
Supplementary Figure 5 from HMGA2 Is a Driver of Tumor Metastasis
2023Open Access
Data from HMGA2 Is a Driver of Tumor Metastasis
2023Open Access
Supplementary Figure 9 from HMGA2 Is a Driver of Tumor Metastasis
2023Open Access
Supplementary Figure 4 from HMGA2 Is a Driver of Tumor Metastasis
2023Open Access
Data from Hypomethylating Therapy in an Aggressive Stroma-Rich Model of Pancreatic Carcinoma
2023Open Access
Supplementary Figure 6 from HMGA2 Is a Driver of Tumor Metastasis
2023Open Access
page 1 of 7Next →

Frequent Co-authors

Paul J. Cannon(11), Argiris Efstratiadis(9), Robert R. Sciacca(8), Apostolos Klinakis(6), Robert E. Michler(6), Ann Marie Schmidt(5), Arline Albala(5), Hanina Hibshoosh(4), Reena Shakya(4), Richard Baer(4), Thomas Ludwig(4), E Athan(4), Stefano Ravalli(4), Thomas Ludwig(3), Ramon Parsons(3), Walif Aji(3), Yan Lü(3), Wu Qu(3), Shunichi Homma(3), Ravichandran Ramasamy(3)